Immuno-oncology networks
Bristol-Myers Squibb II-ON – International Immuno-Oncology Network
We are the first Australian institute to be added to BMS II-ON. II-ON is an international network of leading cancer-research institutions with a focus on advancing immune-oncology for the treatment of cancer, through a series of preclinical, translational, and biology-focused research objectives.
Roche imCORE - Global Cancer Immunotherapy Centers of Research Excellence Network
imCORE is a global network of basic and clinical scientists from 21 leading academic research institutions in cancer immunotherapy. Roche and the network will work collaboratively and with Roche on new medicine, diagnostics, and emerging data to accelerate new treatments in cancer research.
GlaxoSmithKline OCTC – Oncology Clinical and Translational Consortium
A collaborative network to develop innovative patient therapies through rational combination and collaboration with external partners. Parties will share in GSKs early-stage oncology pipeline as well as share expertise in pre-clinical, translational, and clinical development.